Richmond Pharmacology is excited to join the 11th Annual Outsourcing in Clinical Trials Korea 2026 in Seoul, South Korea, on 1–2 December 2026.

As a key regional meeting for clinical operations, outsourcing strategy, and partnership development, OCT Korea brings together leading sponsors, CROs, researchers, and innovative solution providers to explore best practices and real‑world insights shaping the future of clinical trials in Korea and the broader Asia‑Pacific region.

Representing Richmond Pharmacology

  • Stephen Wilkinson, Business Development Manager

Our Focus at the Conference

  • Clinical operations strategy and trial optimisation in Asia‑Pacific
  • CRO partnerships, outsourcing models, and vendor management
  • Regulatory developments and study‑start‑up pathways in Korea
  • Patient recruitment approaches and site engagement practices
  • Innovations enhancing quality, efficiency, and trial delivery

Connect With Us

If you are attending OCT Korea 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

‍

Find out more here: 11th Annual Outsourcing in Clinical Trials Korea 2026 - Arena International

‍

Latest news

Richmond Pharmacology highlights encouraging first-in-human results for Regeneron's investigational RNAi therapy in MASLD

November 12, 2026
NEJM publication and AASLD presentation reports that 79% of treated participants with MASLD and available measurements achieved normal liver fat levels at Week 24 after a single dose of CIDEBsiRNA, alongside improvements in markers of liver injury.
Read more

Upcoming Event

AHA Scientific Sessions 2026

14 - 16 November 2026
Richmond Pharmacology is excited to join the AHA Scientific Sessions 2026 in 14–16 November 2026, on 14–16 November 2026, hosted by the American Heart Association.
View event